Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Cox

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
Cardiovascular Research|June 18, 2021
Chronically elevated branched chain amino acid levels are pro-arrhythmicVincent Portero, Thomas Nicol, Svitlana Podliesna, et al.
Communications Medicine|May 23, 2022
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concernNina Urke Ertesvåg, Julie Xiao, Fan Zhou, et al.
Frontiers in Immunology|October 2, 2024
Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infectionJoanne Byrne, Lili Gu, Alejandro Garcia-Leon, et al.
Nature Communications|November 3, 2023
Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and timeGrace Kenny, Sophie O'Reilly, Neil Wrigley Kelly, et al.
The Lancet. Infectious Diseases|February 20, 2025
Europe needs a sustainably funded influenza research and response networkFlorian Krammer, Wendy S Barclay, Martin Beer, et al.
JCI Insight|November 22, 2019
Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosisJasmohan S Bajaj, Nita Salzman, Chathur Acharya, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 8, 2026
Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) - final reportJannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
Vaccine|May 20, 2023
VACCELERATE Site Network: Real-time definition of clinical study capacity in EuropeJon Salmanton-García, Pauline Wipfler, Paula Valle-Simón, et al.
Vaccines|December 23, 2023
The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE ConsortiumDimitrios Poulimeneas, Markela Koniordou, Dimitra Kousi, et al.
Gut|April 15, 2024
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosisJinxia Liu, Jane MacNaughtan, Annarein J C Kerbert, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Cardiovascular Research|June 18, 2021
Chronically elevated branched chain amino acid levels are pro-arrhythmicVincent Portero, Thomas Nicol, Svitlana Podliesna, et al.
Communications Medicine|May 23, 2022
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concernNina Urke Ertesvåg, Julie Xiao, Fan Zhou, et al.
Frontiers in Immunology|October 2, 2024
Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infectionJoanne Byrne, Lili Gu, Alejandro Garcia-Leon, et al.
Nature Communications|November 3, 2023
Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and timeGrace Kenny, Sophie O'Reilly, Neil Wrigley Kelly, et al.
The Lancet. Infectious Diseases|February 20, 2025
Europe needs a sustainably funded influenza research and response networkFlorian Krammer, Wendy S Barclay, Martin Beer, et al.
JCI Insight|November 22, 2019
Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosisJasmohan S Bajaj, Nita Salzman, Chathur Acharya, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 8, 2026
Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) - final reportJannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
Vaccine|May 20, 2023
VACCELERATE Site Network: Real-time definition of clinical study capacity in EuropeJon Salmanton-García, Pauline Wipfler, Paula Valle-Simón, et al.
Vaccines|December 23, 2023
The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE ConsortiumDimitrios Poulimeneas, Markela Koniordou, Dimitra Kousi, et al.
Gut|April 15, 2024
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosisJinxia Liu, Jane MacNaughtan, Annarein J C Kerbert, et al.
Pageof 16